Reyedar

Reyedar offers a unique solution for screening visual and neurodegenerative diseases by combining eye tracking and Deep Learning, aiming to make it accessible and affordable through fast, objective, and user-friendly testing. They address the limitations of current screening methods for conditions like Glaucoma, Parkinson's, and Multiple Sclerosis, which are often time-consuming, invasive, or unreliable. Their product, SONDA, utilizes AI-powered infrared eye tracking glasses to measure subtle eye movements. A patented algorithm, based on signal processing and Deep Neural Networks, analyzes this complex data, translating it into clear clinical information for early diagnosis and improved patient outcomes.